Key facts
| Recalling firm | Medtronic Sofamor Danek USA Inc |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b) T44135, c) T44145, d) T44150; Demineralized Bone Matrix |
| Classification | Class II |
| Recall number | Z-0165-2024 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Specific serial numbers of GraftonTM DBM product due to the potential that a step during the inspection of the outer Tyvek pouch may not have been performed according to requirements. Based on this, batches may have been released with potential non-conformances in the outer Tyvek pouch. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b) T44135, c) T44145, d) T44150; Demineralized Bone Matrix should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic Sofamor Danek USA Inc. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic Sofamor Danek USA Inc should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic Sofamor Danek USA Inc directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Medtronic Sofamor Danek USA Inc’s FDA history
Argus HQ has recorded 35 total FDA actions tied to Medtronic Sofamor Danek USA Inc: 0 warning letters, 35 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b) T441 recalled?
- Yes. FDA lists a Class II recall by Medtronic Sofamor Danek USA Inc for Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b) T44135, c) T44145, d) T44150; Demineralized Bone Matrix, reported 20231101, with status "Ongoing." FDA recall number: Z-0165-2024.
- What is the recall class for Medtronic Sofamor Danek USA Inc's recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic Sofamor Danek USA Inc- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Catalyft PL & PL40 Expandable Interbody System labeled as follows with correspon… →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Grafton Plus DBM Paste, Model Numbers: a) T45001, b) T45005, c) T45010; Deminera… →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Grafton DBM Crunch, Model Numbers: T44115, Demineralized Bone Matrix →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Grafton DMB Matrix, Model Numbers: a) T42200, b) T42210; Demineralized Bone Matr… →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Grafton DBM (Flex), Model Numbers: T42100, Demineralized Bone Matrix →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Grafton DBM Matrix Strips, Model Numbers: a) T42275, b) T42280; Demineralized Bo… →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Grafton DBM Putty, Model Numbers: a) T43102, b) T43102INT, c) T43103INT, d) T431… →
- Recall: Medtronic Sofamor Danek USA Inc — Class II recall: Magnifuse Bone Graft, Large, Size: 14mm x 25mm, REF 7509014, Human Tissue, Demin… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2023). Recall Record: Class II Recall: Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b)… by Medtronic Sofamor Danek USA Inc. Digital Empire LLC. Retrieved from https://argushq.ai/recall/medtronic-sofamor-danek-usa-z-0165-2024-2023-11-01
"Recall Record: Class II Recall: Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b)… by Medtronic Sofamor Danek USA Inc." Argus HQ Research, Digital Empire LLC, 2023, argushq.ai/recall/medtronic-sofamor-danek-usa-z-0165-2024-2023-11-01.
Argus HQ Research. "Recall Record: Class II Recall: Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b)… by Medtronic Sofamor Danek USA Inc." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/medtronic-sofamor-danek-usa-z-0165-2024-2023-11-01.
@misc{argushq_argushq_ai_recall_medtronic_sofamor_danek_usa_z_0165_2024_2023_11_01_2023,
title = {Recall Record: Class II Recall: Grafton DBM Orthoblend, Model Numbers: a) T44125INT, b)… by Medtronic Sofamor Danek USA Inc},
author = {{Argus HQ Research}},
year = {2023},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/medtronic-sofamor-danek-usa-z-0165-2024-2023-11-01},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

